WPA has introduced mycancerdrugs, a new form of insurance giving access to life-saving cancer drugs not available on the NHS.
The WPA said, many NHS cancer patients have been denied these costly, though potentially life saving treatments, such as Herceptin, Avastin and Tarceva as they await National Institute for Health and Clinical
Julian Stainton, chief executive of WPA, commented: “Cancer is no longer an inevitable death-sentence. Recent and dramatic advances in medical technology make treatments ever more effective. mycancerdrugs helps fund the cost of such advanced drugs where the NHS denies their use. It is now time for this sort of top-up insurance to be available to the public.”
